PML in MS Patients Making Natalizumab-to-Fingolimod SwitchPML in MS Patients Making Natalizumab-to-Fingolimod Switch

A new report describes several cases of PML seen in patients with MS receiving fingolimod, all but 1 of which were treated previously with natalizumab. Authors say this patient had neuromyelitis optica, not MS, with atypical features. Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news